TY - JOUR
T1 - Intravenous Injection of a Lentiviral Vector Encoding NY-ESO-1 Induces an Effective CTL Response
AU - Palmowski, Michael J.
AU - Lopes, Luciene
AU - Ikeda, Yasuhiro
AU - Salio, Mariolina
AU - Cerundolo, Vincenzo
AU - Collins, Mary K.
PY - 2004/2/1
Y1 - 2004/2/1
N2 - Lentiviral vectors can efficiently transduce a variety of nondividing cells, including APCs. We assessed the immunogenicity of a lentiviral vector encoding the melanoma Ag NY-ESO-1 in HLA-A2 transgenic mice. Direct i.v. injection of NY-ESO-1 lentivirus induced NY-ESO-1157-165-specific CD8+ cells, detected ex vivo with an A2/H-2Kb chimeric class I tetramer. These NY-ESO-1157-165-specific CD8+ cells could be expanded by boosting with an NY-ESO-1 vaccinia virus and could kill NY-ESO-1157-165 peptide-pulsed targets in vivo. Such direct lentiviral vector injection was similar in potency to the injection of in vitro-transduced dendritic cells (DC). In addition, human monocyte-derived DC transduced by the NY-ESO-1 lentivirus stimulated an NY-ESO-1 157-165-specific specific CTL clone. These data suggest that direct lentiviral transduction of DC in vivo might provide a powerful immunotherapeutic strategy.
AB - Lentiviral vectors can efficiently transduce a variety of nondividing cells, including APCs. We assessed the immunogenicity of a lentiviral vector encoding the melanoma Ag NY-ESO-1 in HLA-A2 transgenic mice. Direct i.v. injection of NY-ESO-1 lentivirus induced NY-ESO-1157-165-specific CD8+ cells, detected ex vivo with an A2/H-2Kb chimeric class I tetramer. These NY-ESO-1157-165-specific CD8+ cells could be expanded by boosting with an NY-ESO-1 vaccinia virus and could kill NY-ESO-1157-165 peptide-pulsed targets in vivo. Such direct lentiviral vector injection was similar in potency to the injection of in vitro-transduced dendritic cells (DC). In addition, human monocyte-derived DC transduced by the NY-ESO-1 lentivirus stimulated an NY-ESO-1 157-165-specific specific CTL clone. These data suggest that direct lentiviral transduction of DC in vivo might provide a powerful immunotherapeutic strategy.
UR - http://www.scopus.com/inward/record.url?scp=1642444129&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1642444129&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.172.3.1582
DO - 10.4049/jimmunol.172.3.1582
M3 - Article
C2 - 14734738
AN - SCOPUS:1642444129
SN - 0022-1767
VL - 172
SP - 1582
EP - 1587
JO - Journal of Immunology
JF - Journal of Immunology
IS - 3
ER -